Texas Instruments Inc, the largest maker of analog chips, predicted second-quarter profit and sales that may fall short of analysts’ most bullish estimates as some consumer-electronics makers hold off on component purchases.
Profit in the current period will be US$0.39 to US$0.43 a share on revenue of US$2.99 billion to US$3.11 billion, the Dallas-based company said in a statement on Monday.
On average, analysts had estimated a profit of US$0.41 and sales of US$3.06 billion, according to data compiled by Bloomberg. The company said in April profit would be US$0.37 to US$0.45 a share on revenue of US$2.93 billion to US$3.17 billion.
While orders for chips used in industrial machinery and cars have continued to grow, demand is weak for semiconductors used in personal computers and consumer devices such as game consoles, vice president Ron Slaymaker said on a conference call.
Texas Instruments’ chips go into everything from kidney-dialysis machines to DVD players, making its earnings an indicator of demand across the electronics industry.
“PCs will remain a trouble spot for the company,” said Bill Kreher, an analyst at Edward Jones & Co in Des Peres, Missouri. “There may have been an expectation for a reset on guidance and they just narrowed it.”
Texas Instruments shares slipped as much as 3 percent to US$35.52 in late trading, after rising 1.2 percent to US$36.62 at Monday’s close in New York. The stock has gained 19 percent this year, compared with a 23 percent gain in the Philadelphia Semiconductor Index.
Under CEO Richard Templeton, Texas Instruments is exiting the market for digital chips used in smartphones and tablets. Cutting that division is causing total sales to contract from a year earlier.
The company is focusing on the market for analog chips, the semiconductors that convert what happens in the real world — such as touch, sound and pressure — into electronic signals.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained